| P50 | author | Ralf Trappe | Q43106698 |
| P2093 | author name string | Hanno Riess | |
| | Marion Subklewe | |
| | Antonio Pezzutto | |
| | Tuan D Nguyen | |
| | Stephan Oertel | |
| | Antje Schulzki | |
| | Kathrin Sebelin-Wulf | |
| | Matthias Papp-Vary | |
| P2860 | cites work | Cytolytic CD4+-T-Cell Clones Reactive to EBNA1 Inhibit Epstein-Barr Virus-Induced B-Cell Proliferation | Q36890569 |
| | Critical role of EBNA1-specific CD4+ T cells in the control of mouse Burkitt lymphoma in vivo | Q37286445 |
| | Differential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4(+) T-helper 1 responses | Q39607047 |
| | CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines | Q40441967 |
| | Epstein-Barr virus nuclear antigen 1 evades direct immune recognition by CD4+ T helper cells | Q40526255 |
| | Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy | Q40732151 |
| | Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection | Q41464315 |
| | The magnitude and breadth of hepatitis C virus-specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1. | Q42987939 |
| | Phenotypic analysis of antigen-specific T lymphocytes | Q28290058 |
| | Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1. | Q30442797 |
| | Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life | Q33943148 |
| | The role of CD4(+) T helper cells in the cytotoxic T lymphocyte response to HIV-1. | Q33971012 |
| | Epstein-Barr virus (EBV) reactivation in allogeneic stem-cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy. | Q33975142 |
| | CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection. | Q34339494 |
| | Tracking T cells with tetramers: new tales from new tools | Q34632077 |
| | Adoptive therapy with CD8(+) T cells: it may get by with a little help from its friends | Q35001627 |
| | CD4+ T cell responses in the immune control against latent infection by Epstein-Barr virus | Q35141129 |
| | Distinct memory CD4+ T-cell subsets mediate immune recognition of Epstein Barr virus nuclear antigen 1 in healthy virus carriers | Q35616090 |
| | Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins. | Q36228567 |
| | Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies | Q36231550 |
| | Malignancy after transplantation | Q36298305 |
| | Epitope focusing in the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memory | Q36367550 |
| | Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children | Q36404594 |
| | Impaired recovery of Epstein-Barr virus (EBV)--specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease | Q43563921 |
| | EBV-specific memory CD8+ T cell phenotype and function in stable solid organ transplant patients | Q43652958 |
| | Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.1 | Q43776460 |
| | Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease | Q44013382 |
| | Novel method for detection of virus-specific CD41+ T cells indicates a decreased EBV-specific CD4+ T cell response in untreated HIV-infected subjects | Q45508924 |
| | Relationship between CD8+ T-cell phenotype and function, Epstein-Barr virus load, and clinical outcome in pediatric renal transplant recipients: a prospective study | Q45626273 |
| | Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells | Q45730808 |
| | Presentation of epstein-barr virus latency antigens to CD8(+), interferon-gamma-secreting, T lymphocytes | Q45745651 |
| | Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation | Q45780110 |
| | CD4 lymphocytopenia as a risk factor for skin cancers in renal transplant recipients. | Q50885968 |
| | Loss of EBNA1-specific memory CD4+ and CD8+ T cells in HIV-infected patients progressing to AIDS-related non-Hodgkin lymphoma. | Q51990543 |
| | Identification of prognostic factors in 61 patients with posttransplantation lymphoproliferative disorders. | Q53329306 |
| | Immune control of HIV-1 after early treatment of acute infection | Q56961920 |
| | Donor T cells to treat EBV-associated lymphoma | Q72110900 |
| | Persistent numbers of tetramer+ CD8(+) T cells, but loss of interferon-gamma+ HIV-specific T cells during progression to AIDS | Q77768092 |
| | Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation | Q79213173 |
| | Differences between early and late posttransplant lymphoproliferative disorders in solid organ transplant patients: are they two different diseases? | Q81308307 |
| | Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the Israel Penn International Transplant Tumor Registry experience | Q81507567 |
| | Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course | Q83062052 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 203-210 | |
| P577 | publication date | 2006-11-29 | |
| P1433 | published in | Transplant Immunology | Q15758510 |
| P1476 | title | Quantitative analysis of EBV-specific CD4/CD8 T cell numbers, absolute CD4/CD8 T cell numbers and EBV load in solid organ transplant recipients with PLTD. | |
| P478 | volume | 17 | |